05/09/2008 (Agence Europe) - The European Medicines Agency (EMEA) has recently published guidelines for companies developing medicines for the treatment of Alzheimer's disease, Parkinson's disease and other diseases of the central nervous system. The documents may be consulted on the Agency's website: www.emea.europa.eu (O.J./transl.jl)